Literature DB >> 32204087

A powerful combination of copper-cysteamine nanoparticles with potassium iodide for bacterial destruction.

Xiumei Zhen1, Lalit Chudal2, Nil Kanatha Pandey2, Jonathan Phan2, Xin Ran3, Eric Amador2, Xuejing Huang2, Omar Johnson2, Yuping Ran3, Wei Chen4, Michael R Hamblin5, Liyi Huang6.   

Abstract

Herein, for the first time, we demonstrate that the combination of copper-cysteamine (Cu-Cy) nanoparticles (NPs) and potassium iodide (KI) can significantly inactivate both Gram-positive MRSA and Gram-negative E. coli. To uncover the mystery of the killing, the interaction of KI with Cu-Cy NPs was investigated systematically and the products from their interaction were identified. No copper ions were released after adding KI to Cu-Cy NPs in cell-free medium and, therefore, it is reasonable to conclude that the Fenton reaction induced by copper ions is not responsible for the bacterial killing. Based on the observations, we propose that the major killing mechanism involves the generation of toxic species, such as hydrogen peroxide, triiodide ions, iodide ions, singlet oxygen, and iodine molecules. Overall, the powerful combination of Cu-Cy NPs and KI has good potential as an independent treatment or a complementary antibiotic treatment to infectious diseases.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacterial killing; Copper; Copper-cysteamine; Nanoparticles; Photodynamic therapy; Photosensitizer; Potassium iodide; Reactive iodine species

Mesh:

Substances:

Year:  2020        PMID: 32204087      PMCID: PMC7100965          DOI: 10.1016/j.msec.2020.110659

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  35 in total

1.  Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.

Authors:  Yunsong Zhang; Tianhong Dai; Min Wang; Daniela Vecchio; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015-03       Impact factor: 5.307

Review 2.  Porins and specific diffusion channels in bacterial outer membranes.

Authors:  H Nikaido
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

Review 3.  Structure and biodistribution relationships of photodynamic sensitizers.

Authors:  R W Boyle; D Dolphin
Journal:  Photochem Photobiol       Date:  1996-09       Impact factor: 3.421

4.  A New Modality for Cancer Treatment--Nanoparticle Mediated Microwave Induced Photodynamic Therapy.

Authors:  Mengyu Yao; Lun Ma; Lihua Li; Junying Zhang; Rebecca Lim; Wei Chen; Yu Zhang
Journal:  J Biomed Nanotechnol       Date:  2016-10       Impact factor: 4.099

5.  Investigation of copper-cysteamine nanoparticles as a new photosensitizer for anti-hepatocellular carcinoma.

Authors:  Xuejing Huang; Fengjie Wan; Lun Ma; Jonathan B Phan; Rebecca Xueyi Lim; Cuiping Li; Jiagui Chen; Jinghuan Deng; Yasi Li; Wei Chen; Min He
Journal:  Cancer Biol Ther       Date:  2019-02-06       Impact factor: 4.742

6.  Comparison of killing of gram-negative and gram-positive bacteria by pure singlet oxygen.

Authors:  T A Dahl; W R Midden; P E Hartman
Journal:  J Bacteriol       Date:  1989-04       Impact factor: 3.490

7.  Potassium iodide remains the most effective therapy for cutaneous sporotrichosis.

Authors:  K Sandhu; S Gupta
Journal:  J Dermatolog Treat       Date:  2003-12       Impact factor: 3.359

Review 8.  The chemistry and applications of antimicrobial polymers: a state-of-the-art review.

Authors:  El-Refaie Kenawy; S D Worley; Roy Broughton
Journal:  Biomacromolecules       Date:  2007-04-11       Impact factor: 6.988

9.  Theoretical studies on the energy structures and optical properties of copper cysteamine - a novel sensitizer.

Authors:  Marc Alias; Noura D Alkhaldi; Mar Reguero; Lun Ma; Junying Zhang; Coen de Graaf; Muhammad N Huda; Wei Chen
Journal:  Phys Chem Chem Phys       Date:  2019-09-17       Impact factor: 3.676

Review 10.  Microbe-host interactions: structure and role of Gram-negative bacterial porins.

Authors:  Stefania Galdiero; Annarita Falanga; Marco Cantisani; Rossella Tarallo; Maria Elena Della Pepa; Virginia D'Oriano; Massimiliano Galdiero
Journal:  Curr Protein Pept Sci       Date:  2012-12       Impact factor: 3.272

View more
  6 in total

1.  A recyclable and light-triggered nanofibrous membrane against the emerging fungal pathogen Candida auris.

Authors:  Xinyao Liu; Chuan Guo; Kaiwen Zhuang; Wei Chen; Muqiu Zhang; Yalin Dai; Lin Tan; Yuping Ran
Journal:  PLoS Pathog       Date:  2022-05-25       Impact factor: 7.464

2.  Combination of Disulfiram and Copper-Cysteamine Nanoparticles for an Enhanced Antitumor Effect on Esophageal Cancer.

Authors:  Yan Chang; Fang Wu; Nil Kanatha Pandey; Lalit Chudal; Meiying Xing; Xiaoli Zhang; Linh Nguyen; Xian Liu; J Ping Liu; Wei Chen; Zui Pan
Journal:  ACS Appl Bio Mater       Date:  2020-09-09

3.  Effects of Nanoparticle Size and Radiation Energy on Copper-Cysteamine Nanoparticles for X-ray Induced Photodynamic Therapy.

Authors:  Bindeshwar Sah; Jing Wu; Adam Vanasse; Nil Kanatha Pandey; Lalit Chudal; Zhenzhen Huang; Wenzhi Song; Hongmei Yu; Lun Ma; Wei Chen; Michael P Antosh
Journal:  Nanomaterials (Basel)       Date:  2020-06-01       Impact factor: 5.076

Review 4.  Advances in Nanostructures for Antimicrobial Therapy.

Authors:  Josef Jampilek; Katarina Kralova
Journal:  Materials (Basel)       Date:  2022-03-24       Impact factor: 3.623

5.  Formulation of pH-responsive PEGylated nanoparticles with high drug loading capacity and programmable drug release for enhanced antibacterial activity.

Authors:  Dawei Li; Guoke Tang; Hui Yao; Yuqi Zhu; Changgui Shi; Qiang Fu; Fei Yang; Xing Wang
Journal:  Bioact Mater       Date:  2022-02-24

Review 6.  Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies.

Authors:  Raphaëlle Youf; Max Müller; Ali Balasini; Franck Thétiot; Mareike Müller; Alizé Hascoët; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.